Enteric softgel capsules
Enteric softgel capsules comprise a fill material and an enteric shell composition, characterized in that the enteric nature of the capsules may be achieved without an enteric coating or added conventional enteric polymers.
1. A stable enteric softgel capsule comprising:
(a) a fill material; and
(b) an enteric shell composition,
wherein the stable enteric softgel capsule has been dried,
wherein the fill material comprises at least one pharmaceutically active ingredient,
wherein, prior to the enteric softgel capsule being dried, the enteric shell composition comprises 2.75% w/w to about 10% w/w of a polysaccharide, wherein the polysaccharide is a carrageenan and is the sole polysaccharide in the enteric shell composition, and wherein the carrageenan is iota carrageenan and does not comprise kappa carrageenan,
about 10% w/w to about 30% w/w of a gelatin,
about 10% w/w to about 35% w/w of a plasticizer, and
about 20% w/w to about 50 w/w of a solvent, and
wherein the enteric softgel capsule is free of conventional enteric polymers,
wherein the enteric softgel capsule is stable for 0 up to 6 months at 25° C./60% relative humidity (RH) and 30° C./75% RH.
2. The enteric softgel capsule of claim 1 , wherein the gelatin comprises at least one of Type A gelatin, Type B gelatin and mixtures thereof.
3. The enteric softgel capsule of claim 1 , wherein the gelatin comprises at least one of fish gelatin, hide gelatin, bone gelatin and mixtures thereof.
4. The enteric softgel capsule of claim 2 , wherein the gelatin is the Type B high bloom gelatin.
5. The enteric softgel capsule of claim 2 , wherein the gelatin is the Type A high bloom gelatin.
6. The enteric softgel capsule of claim 1 , wherein the plasticizer comprises at least one of glycerol, glycerin, sorbitol and mixtures thereof.
7. The enteric softgel capsule of claim 6 , wherein the plasticizer is glycerol.
8. The enteric softgel capsule of claim 1 , wherein the solvent is water.
9. The enteric softgel capsule of claim 1 further comprising a buffer.
10. The enteric softgel capsule of claim 1 , wherein the capsule disintegrates in about one hour, about two hours, about three hours, about four hours, or about five hours in an acidic medium.
11. The enteric softgel capsule of claim 1 , therein the fill material has a pH of about 2.5 to about 6.5, or about 3.0 to about 6.0, or about 3.5 to about 5.5.
12. A process of preparing an enteric softgel capsule according to claim 1 comprising the steps of:
(a) preparing a fill material; and
(b) encapsulating the fill material with the enteric shell composition.
13. The process of claim 12 , further comprising preparing the enteric shell composition by adding the solvent, the glycerin and the gelatin to a melter to form a mixture.
14. The process of claim 13 , comprising mixing the mixture at a temperature of about 70° C. to about 80° C. under vacuum.
15. The process of claim 14 , further comprising heating the mixture to a temperature of about 82° C. to about 85° C.
16. The process of claim 13 , further comprising combining the mixture with a premix of the carrageenan and the plasticizer.
17. The process of claim 12 , further comprising, drying the enteric shell composition.
18. A stable enteric softgel capsule comprising:
(a) a fill material; and
(b) an enteric shell composition,
wherein the stable enteric softgel capsule has been dried,
wherein the fill material comprises at least one pharmaceutically active ingredient,
wherein, prior to the enteric softgel capsule being dried, the enteric shell composition comprises 2.75% w/w to about 10% w/w of a polysaccharide, wherein the polysaccharide is a carrageenan and is the sole polysaccharide in the enteric shell composition, and wherein the carrageenan is iota carrageenan and does not comprise kappa carrageenan,
about 10% w/w to about 30% w/w of a gelatin,
about 10% w/w to about 35% w/w of a plasticizer,
about 20% w/w to about 50 w/w of a solvent, and
about 0.1% w/w to about 3% w/w of a buffer and/or an alkalizing agent, and
wherein the enteric softgel capsule is free of conventional enteric polymers,
wherein the enteric softgel capsule is stable for 0 up to 6 months at 25° C./60% RH and 30° C./75% RH.
19. The enteric softgel capsule of claim 18 , wherein the buffer is disodium phosphate.